{"Title": "Consensus on precision medicine for metastatic cancers: A report from the MAP conference", "Year": 2016, "Source": "Ann. Oncol.", "Volume": "27", "Issue": 8, "Art.No": null, "PageStart": 1443, "PageEnd": 1448, "CitedBy": 60, "DOI": "10.1093/annonc/mdw192", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84985038330&origin=inward", "Abstract": "\u00a9 The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.Recent advances in biotechnologies have led to the development of multiplex genomic and proteomic analyses for clinical use. Nevertheless, guidelines are currently lacking to determine which molecular assays should be implemented in metastatic cancers. The first MAP conference was dedicated to exploring the use of genomics to better select therapies in the treatment of metastatic cancers. Sixteen consensus items were covered. There was a consensus that new technologies like next-generation sequencing of tumors and ddPCR on circulating free DNA have convincing analytical validity. Further work needs to be undertaken to establish the clinical utility of liquid biopsies and the added clinical value of expanding from individual gene tests into large gene panels. Experts agreed that standardized bioinformatics methods for biological interpretation of genomic data are needed and that precision medicine trials should be stratified based on the level of evidence available for the genomic alterations identified.", "AuthorKeywords": ["Biomarkers", "Consensus", "Precision medicine"], "IndexKeywords": ["Genomics", "High-Throughput Nucleotide Sequencing", "Humans", "Molecular Targeted Therapy", "Neoplasms", "Precision Medicine", "Proteomics"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84985038330", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"]], "AuthorData": {"7005912775": {"Name": "Swanton C.", "AuthorID": "7005912775", "AffiliationID": "60024544", "AffiliationName": "UCL Hospitals and Cancer Institute"}, "54956605300": {"Name": "McGranahan N.", "AuthorID": "54956605300", "AffiliationID": "60107285", "AffiliationName": "Translational Cancer Therapeutics Laboratory, The Francis Crick Institute"}, "7201420394": {"Name": "Soria J.C.", "AuthorID": "7201420394", "AffiliationID": "60106210", "AffiliationName": "Department of Medical Oncology, INSERM Unit U981, Facult\u00e9 de medicine Paris-Sud XI"}, "7102504411": {"Name": "Andr\u00e9 F.", "AuthorID": "7102504411", "AffiliationID": "60106210", "AffiliationName": "Department of Medical Oncology, INSERM Unit U981, Facult\u00e9 de medicine Paris-Sud XI"}, "7006937523": {"Name": "Bardelli A.", "AuthorID": "7006937523", "AffiliationID": "60070526", "AffiliationName": "Candiolo Cancer Institute-FPO, IRCCS"}, "6602158065": {"Name": "Biankin A.", "AuthorID": "6602158065", "AffiliationID": "60018058", "AffiliationName": "West of Scotland Pancreatic Unit, Glasgow Royal Infirmary"}, "7006688992": {"Name": "Caldas C.", "AuthorID": "7006688992", "AffiliationID": "114286992", "AffiliationName": "Cambridge Experimental Cancer Medicine Centre, NIHR Cambridge Biomedical Research Centre"}, "6604022727": {"Name": "Rosenfeld N.", "AuthorID": "6604022727", "AffiliationID": "60031101, 60120009", "AffiliationName": "Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre"}, "23491545400": {"Name": "Chandarlapaty S.", "AuthorID": "23491545400", "AffiliationID": "60009343", "AffiliationName": "Department of Medicine, Memorial Sloan Kettering Cancer Center"}, "23033712000": {"Name": "de Koning L.", "AuthorID": "23033712000", "AffiliationID": "60030640, 60108665", "AffiliationName": "Department of Translational Research, Institut Curie, PSL Research University"}, "7004424860": {"Name": "Dive C.", "AuthorID": "7004424860", "AffiliationID": "60120602, 60003771", "AffiliationName": "Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute, The University of Manchester"}, "57200979512": {"Name": "Feunteun J.", "AuthorID": "57200979512", "AffiliationID": "60106080, 60106017", "AffiliationName": "Stabilit\u00e9 G\u00e9n\u00e9tique et Oncogen\u00e8se, Universit\u00e9 Paris-Sud, Gustave-Roussy"}, "7202044886": {"Name": "Leung S.Y.", "AuthorID": "7202044886", "AffiliationID": "60006541, 60033020", "AffiliationName": "Department of Pathology, The University of Hong Kong, Queen Mary Hospital"}, "7004997584": {"Name": "Marais R.", "AuthorID": "7004997584", "AffiliationID": "60120602, 60003771", "AffiliationName": "Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester"}, "7003499321": {"Name": "Mardis E.R.", "AuthorID": "7003499321", "AffiliationID": "60022756", "AffiliationName": "McDonnell Genome Institute, Washington University School of Medicine"}, "57206029349": {"Name": "Middleton G.", "AuthorID": "57206029349", "AffiliationID": "60026493", "AffiliationName": "Department of Oncology, University Hospitals Birmingham NHS Foundation Trust"}, "12762916100": {"Name": "Quezada S.A.", "AuthorID": "12762916100", "AffiliationID": "60022148", "AffiliationName": "Cancer Immunology Unit, University College London Cancer Institute, University College London"}, "35269968300": {"Name": "Rod\u00f3n J.", "AuthorID": "35269968300", "AffiliationID": "60110094", "AffiliationName": "Vall d'Hebron Institute of Oncology (VHIO)"}, "7004590640": {"Name": "Sotiriou C.", "AuthorID": "7004590640", "AffiliationID": "60028724, 60000145", "AffiliationName": "Breast Cancer Translational Research Laboratory-BCTL (ULB 290), Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB)"}}}